Trial reportAesthetic plastic surgery2026
Enhancing Postoperative Analgesia in Breast Reduction Surgery: The Combined Effect of Pectointercostal Fascial Plane Block and Serratus Anterior Plane Block.
Trial report in Aesthetic plastic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Reply to Bozkurt et al.: Not Just Pain Relief-Fascial Plane Block Combination as a Primary Anesthetic Technique in Breast Implant Removal.Aesthetic plastic surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPectointercostal Fascial Plane Block (PIFB) targets the anterior cutaneous branches of the intercostal nerves and provides analgesia to the anteromedial chest wall. In this study, we aimed to evaluate the effect of PIFB in addition to Serratus Anterior Plane Block (SAPB) on postoperative morphine consumption and pain scores in breast reduction surgery. MATERIALS AND
methodsSixty-four ASA I-II patients (≥18 years) were randomly assigned to two groups. General anesthesia was induced with propofol, rocuronium, fentanyl, and maintained with sevoflurane and remifentanil. After intubation: Group I (PIFB + SAPB) received bilateral PIFB (15 mL 0.25% bupivacaine) and SAPB (20 mL 0.25% bupivacaine). Group II (SAPB only) received SAPB (20 mL 0.25% bupivacaine) only. Postoperative analgesia included IV morphine patient-controlled analgesia (1 mg bolus, 10-min lockout, 4-hour limit: 10 mg). Outcomes measured were stay in postanesthesia care unit time (PACU), 24-hour morphine consumption, morphine demands, VAS scores (rest and movement), additional analgesic use, and complications.
resultsBoth groups had similar demographics, surgical duration, and PACU stay. 24-hour morphine consumption was lower in Group I (3.7±2.2 mg vs. 7.9±2.3 mg, p<0.05). Morphine demands were lower in Group I (4.5±2.7 vs. 10.4±3.7, p<0.05). VAS scores (rest and movement) were lower in Group I (p<0.05). Rescue analgesic requirement was lower in Group I than in Group I (p=0.01). No complications occurred in both groups.
conclusionPIFB combined with SAPB significantly reduces morphine consumption and pain scores in breast reduction surgery without complications. LEVEL OF EVIDENCE I: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Indexed as
Identifiers
40815379What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.